Skip to content

Simplexa™ Group A Strep Positive Control Pack MOL2860

by DiaSorin Molecular LLC

Ref MOL2860

Simplexa™ Group A Strep Positive Control Pack MOL2860 is a device classified as IVD General (EU), Class II (US) made by DiaSorin Molecular LLC, registered in EUDAMED on 5 Oct 2026 (Basic UDI-DI B-20816101025576), cleared under FDA 510(k) K143651 on 18 Mar 2015 and listed in FDA GUDID since 22 Sep 2016 (UDI-DI 20816101025576), active as of 7 Nov 2026. One FDA recall is linked to it.

Active European Union and United States. Also listed in GUDID (US).

CE IVDD 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None ongoing

1 closed

Documents

None linked in EUDAMED

A group certificate may exist

510(k) K143651

FDA submission, from GUDID

Trust

Unverified

Source EUDAMED, GUDID, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-20816101025576 Basic UDI-DI 20816101025576UDI-DIDate5 Oct 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number20816101025576 UDI-DI Date22 Sep 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE GUDID from GUDID Substantially Equivalent · Traditional NumberK143651 Date18 Mar 2015DecidedStatusActive

Official records

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI B-20816101025576 registered 5 Oct 2026 Active
  • FDA 510(k) K143651 decided 18 Mar 2015 Active
  • FDA GUDID UDI-DI 20816101025576 listed 22 Sep 2016 Listed

Recalls

1 recall · FDA

    • Terminated Z-1274-2016 FDA Class I initiated 10 Feb 2016

    Focus Diagnostics is recalling the Direct Amplification Discs (DAD) supplied with the Simplexa HSV 1 & 2 Direct (MOL2150), Simplexa Flu A/B & RSV Direct (MOL2650) and Simplexa Group A Strep Direct kits (MOL2850) because it may result in a false negative result, a false positive result or Error code (s) 500 or 505, and it may result in higher invalid rates.

Timeline

4 dated events

  1. Cleared FDA 510(k) K143651
  2. Recall initiated FDA recalls Z-1274-2016
  3. Listed FDA GUDID 20816101025576
  4. Registered EUDAMED B-20816101025576

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · GUDID

Trade name
Simplexa™ Group A Strep Positive Control Pack
Generic name
Beta-haemolytic Group A Streptococcus nucleic acid IVD, control
Model / Ref / Catalog
MOL2860
Primary DI / UDI-DI
20816101025576
Basic UDI-DI
B-20816101025576
510(k) Number
FDA product code
PGX
EMDN code
W0105080808 All infectious diseases controls - nat
GMDN term
Beta-haemolytic Group A Streptococcus nucleic acid IVD, control
Device class
Class IVD General EUDAMED
Class II GUDID
Regulation number
866.2680
EU registration type
Legacy device (under a directive)
EU market of registration
Italy
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IVD General
GUDID
Class II

Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under ALL INFECTIOUS DISEASES CONTROLS - NAT.

Other devices from DiaSorin Molecular LLC

See all devices from DiaSorin Molecular LLC →

Properties

  • Contains substances of microbial origin
  • Reagent
  • IVD kit
  • Professional testing
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (17, all answered No)